StockWatch
·

HIKAL LTD. Q4 FY26 Results

HIKALQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue519.405.1%6.0%
Total Income526.005.8%4.9%
Expenditure470.600.5%2.9%
PBT8.30190.2%87.8%
Net Profit14.40344.1%71.3%
OPM11.22%2.18pp11.12pp
NPM2.74%3.93pp6.34pp
EPS1.17143.8%71.3%
View full financials

Hikal Ltd FY26: Revenue ₹1,713 Cr, PAT ₹14 Cr

27 May 2026 · 27 May, 5:02 pm

Summary

Hikal Ltd. announced its audited financial results for Q4 and the full financial year ended March 31, 2026. For Q4FY26, the company reported consolidated revenue of ₹519 crore, with an EBITDA of ₹105 crore and a margin of 20.3%. Profit after tax for the quarter was ₹14 crore, indicating a recovery from a loss in the previous quarter. For the entire fiscal year 2026, Hikal posted a consolidated revenue of ₹1,713 crore with an EBITDA margin of 12.9%. Management highlighted a decisive shift from remediation to sustainable growth, citing improvements in operating performance, strengthened quality systems, and strategic investments in future-ready capabilities as key drivers, noting that the worst of the volume cycle in Crop Protection appears to be over.

Key Highlights

  1. 1

    Hikal Limited reported consolidated revenue of ₹519 crore for Q4FY26, which is an increase of approximately 5.1% quarter-on-quarter, despite a year-on-year decrease of about 6%.

  2. 2

    Consolidated EBITDA for Q4FY26 stood at ₹105 crore, with an EBITDA margin of 20.3%, showing a quarter-on-quarter growth of 26.5% but a year-on-year decline of 14.6%.

  3. 3

    Profit after tax (PAT) for Q4FY26 was ₹14 crore, a significant recovery from a loss of ₹6 crore in Q3FY26, although it represents a 72% decrease from ₹50 crore in Q4FY25.

  4. 4

    For the full financial year 2026, the company achieved a consolidated revenue of ₹1,713 crore and an EBITDA margin of 12.9%.

  5. 5

    The Crop Protection business demonstrated robust performance in Q4FY26, with revenues growing by 45% quarter-on-quarter and 13% year-on-year to ₹228 crore.

  6. 6

    Hikal’s board approved a final dividend of 20% of face value, bringing the total dividend for the financial year to 30%.

  7. 7

    Strategic investments in HPAPI and ADC-related chemistries, alongside an expanded Pune kilo lab, are strengthening the company's integrated end-to-end CDMO capabilities.

Informational and educational content only. Not investment advice.